Status:
UNKNOWN
Bronchoscopic Microwave Intervention Treatment in Advanced Central NSCLC
Lead Sponsor:
Shanghai Pulmonary Hospital, Shanghai, China
Conditions:
Effect Increased
Safety Issues
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
A randomized, prospective study of the efficacy and safety of the first-line treatment in advanced central non-small cell lung cancer patients by anti-PD-1 / PD-L1 monoclonal antibody and chemotherapy...
Detailed Description
This study is a randomized, prospective study, which will analyze the efficacy and safety of the first-line treatment in advanced central non-small cell lung cancer patients by anti-PD-1 / PD-L1 monoc...
Eligibility Criteria
Inclusion
- advanced central non-small cell lung cancer patients, untreated, tolerating bronchoscopy
Exclusion
- contraindications to tracheoscopy, chemotherapy, and immunotherapy
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04360655
Start Date
May 1 2020
End Date
May 1 2023
Last Update
April 24 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.